Zymeworks, Inc. (ZYME)
25.41
-0.20
(-0.78%)
USD |
NASDAQ |
May 26, 15:19
Zymeworks EPS Diluted (Quarterly) : -0.592 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| AbbVie, Inc. | 0.3861 |
| Aldeyra Therapeutics, Inc. | -0.0572 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.16M |
| Revenue (Quarterly) | 2.408M |
| Total Expenses (Quarterly) | 46.57M |
| Enterprise Value | 1.783B |
| Gross Profit Margin (Quarterly) | -18.23% |
| Profit Margin (Quarterly) | -1.83K% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.372 |